fashion -WSS

fashion

author：comprehensive 2025-10-01 06:01:45 - browse：12

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Cuban government calls US nuclear submarine stop a 'provocative escalation'

WSS

Antibody drugs appear effective. Now can we make enough of them?

Superbugs, antibiotic resistance get scrutiny in congress

Cuban government calls US nuclear submarine stop a 'provocative escalation'

A Greenpeace activist is fined for crash

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Inflation cooled significantly in June, bringing price hikes close to normal levels

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

New air purifier tech could be key to improving indoor air quality

FDA approves RSV monoclonal antibody for infants, toddlers

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

As digital health tech proliferates, a new institute aims to cut through hype

Continuity nursing helped my family in our darkest PICU moments

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Medicare details structure of new drug price negotiation program

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Google and Epic fight stronger regulation of AI in health care

focus

WHO calls for emergency meeting on new China virus, as cases spread

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Biden tests positive for Covid

Medicare to cover more brain scans for Alzheimer’s patients

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

knowledge

focus

knowledge

hotspot